The ESMO TAT Asia Congress 2025 will be held in Hong Kong SAR, China on July 18-20. This multi-stakeholder forum brings together key players in cancer drug development, providing a platform to share the latest advances in early clinical trials across the region.
The congress, organized by the European Society for Medical Oncology, will feature in-depth discussions on vital topics such as innovation, digital transformation, research methodology, business insights, regulation, and public policy. ESMO TAT Asia aims to drive progress in cancer treatment and research.
Set in the vibrant city of Hong Kong, the congress promises to be a dynamic gathering of industry leaders, academics, clinicians, and regulators, fostering international cooperation and accelerating anticancer research.
Don’t miss this opportunity to be part of the conversation and stay tuned for registration details.
Find more information about ESMO at OncoDaily.com.
